Arabesque Asset Management’s Thermo Fisher Scientific TMO Stock Holding History

Arabesque Asset Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,160	Closed	-$3.94M	–	115
2022 Q4	$3.94M	Buy	7,160 +3,189	+80%	+$1.69M	1.33%	18
2022 Q3	$2.01M	Sell	3,971 -165	-4%	-$92.3K	0.98%	52
2022 Q2	$2.25M	Buy	4,136 +318	+8%	+$175K	1.18%	15
2022 Q1	$2.25M	Buy	+3,818	New	+$2.19M	0.78%	57
2021 Q4	–	Sell	-7,652	Closed	-$4.37M	–	203
2021 Q3	$4.37M	Buy	+7,652	New	+$4.2M	1.46%	4
2021 Q2	–	Sell	-17,131	Closed	-$7.82M	–	159
2021 Q1	$7.82M	Buy	17,131 +11,347	+196%	+$5.42M	3.46%	7
2020 Q4	$2.69M	Buy	+5,784	New	+$2.71M	0.81%	28

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Arabesque Asset Management's TMO Position: Q1 2023 in Review

Arabesque Asset Management sold out of Thermo Fisher Scientific (TMO) in Q1 2023, closing a stake of 7,160 shares — an estimated $3.94M sold.

Arabesque Asset Management first reported a position in TMO in Q4 2020 and held it in 7 quarters. The position peaked at $7.82M in Q1 2021. 2,387 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

Arabesque Asset Management reported no remaining Thermo Fisher Scientific position as of Q1 2023 after selling out during the quarter.
Arabesque Asset Management sold 7,160 Thermo Fisher Scientific shares in Q1 2023, an estimated $3.94M.
Arabesque Asset Management first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 7 quarters.
Arabesque Asset Management's Thermo Fisher Scientific position peaked at $7.82M in Q1 2021.
2,387 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.